Chronic Lower Back Pain Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Non-steroidal Anti-Inflammatory Drugs, Antidepressants, Analgesic, Opioids, and Others), By Route of Administration (Oral, Topical, and Others), By Distribution Channel (Hospital Pharmacies and Retail & Online Pharmacies), and Regional Forecast, 2023-2030

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI100575

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2019-2021
Growth Rate	CAGR of 9.5% from 2023 to 2030
Unit	Value (USD billion)
Segmentation	By Drug Class, Route of Administration, Distribution Channel, and Region
By Drug Class	Non-steroidal Anti-Inflammatory Drugs Antidepressants Analgesic Opioids Others
By Route of Administration	Oral Topical Others
By Distribution Channel	Hospital Pharmacies Retail & Online Pharmacies
By Region	North America (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region) U.S. Canada Europe (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region) U.K. Germany France Italy Spain Scandinavia Rest of Europe Asia Pacific (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region) China India Japan Australia Southeast Asia Rest of Asia Pacific Latin America (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region) Brazil Mexico Rest of Latin America Middle East & Africa (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region) GCC South Africa Rest of Middle East & Africa